Targeting the untargetable: oncolytic virotherapy for the cancer stem cell.
Liu
Ta-Chiang
TC
Jennerex Biotherapeutics, Inc., San Francisco, California 94105, USA.
Kirn
David
D
D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D014411:Neoplastic Stem Cells / Q000821:virology; D018406:Virus Physiological Phenomena